GlassScriptPhysician profile
Kimberly Capone
NPI 1174508063
$1,726.63
in general payments reported to CMS, 2019-2025
24 companies · $286 in 2025
The $286 reported for 2025 was more than what a typical Obstetrics & Gynecology (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $798 · 2022: $141 · 2023: $274 · 2024: $228 · 2025: $286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $788.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $787.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Renovia INC | $302.03 | 2021 | |
| Mayne Pharma Commercial LLC | $233.24 | 2021-2025 | |
| Daiichi Sankyo INC. | $178.97 | 2022-2024 | Injectafer |
| Therapeuticsmd, INC. | $130.08 | 2021 | |
| Abbvie INC. | $125.95 | 2021 | |
| Sumitomo Pharma America, INC. | $107.99 | 2023-2025 | Gemtesa, Myfembree |
| Aspira Women'S Health INC | $100.60 | 2021 | |
| Coopersurgical, INC. | $88.69 | 2021-2024 | Summit Doppler, Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $59.93 | 2023-2025 | |
| Astellas Pharma US INC | $54.39 | 2023-2024 | Veozah, Myrbetriq |
| Axonics, INC. | $50.53 | 2023-2024 | Axonics |
| Hologic Sales and Service, LLC | $41.44 | 2021-2023 | Thinprep 2000 Processor, Aptima |
| Organon LLC | $37.58 | 2023-2025 | Nexplanon |
| Sage Therapeutics, LLC | $31.38 | 2025 | Zurzuvae |
| Scynexis, INC. | $28.82 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $24.70 | 2023 | Tymlos |
| Merck Sharp & Dohme LLC | $19.32 | 2025 | Gardasil 9 |
| Vertex Pharmaceuticals Incorporated | $17.21 | 2025 | |
| Mylan Pharmaceuticals INC. | $16.91 | 2021 | |
| Evofem Biosciences, INC. | $16.74 | 2021 | |
| Medtronic, INC. | $16.59 | 2022 | |
| Distalmotion US | $15.07 | 2025 | Dexter L6 Robot |
| Ethicon US, LLC | $14.50 | 2023 | Vistaseal, Dermabond, Stratafix |
| Agile Therapeutics, INC. | $13.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Capone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.